Screening for Genes in Patients With Congenital Neutropenia
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DIJON · Aug 10, 2016
Trial Information
Current as of May 22, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Persons who have provided written consent
- • Patients with congenital neutropenia and mental retardation and/or a development anomaly (malformation, facial dysmorphism)
- • Patients who accept a clinical evaluation, and to give at least one blood sample
- • Screening for chromosomal microrearrangements by normal array-CGH
- Exclusion Criteria:
- • Persons without national health insurance cover
- • Patients who do not meet the clinical and/or biological criteria
- • Refusal to give written consent to take part in the study
- • Refusal to give a blood sample
- • Blood samples from parents not available
About Centre Hospitalier Universitaire Dijon
The Centre Hospitalier Universitaire Dijon (CHU Dijon) is a leading academic medical institution in France, dedicated to advancing healthcare through innovative research and clinical trials. With a focus on patient-centered care, CHU Dijon integrates comprehensive medical services with cutting-edge research initiatives across various specialties. The institution is committed to enhancing clinical outcomes and improving health standards by facilitating rigorous scientific investigations and collaborations with national and international partners. By prioritizing ethical practices and adherence to regulatory standards, CHU Dijon aims to contribute significantly to the development of new therapies and medical technologies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dijon, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials